MedTrace Logo

Single In-Clinic Encounter With the Notal Vision Home OCT

NCT04642183 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2021-12-23

No results posted yet for this study

Summary

this is a single In-Clinic Encounter With the Notal Vision Home OCT study. The study population will include up to 50 Age-related Macular Degeneration patients diagnosed with wet NV-AMD in at least one eye at the time of enrollment. All enrolled subjects should have at least one eye with active (wet) CNV (SRF and/or IRF) at the time of enrollment. All subjects will be enrolled at 1 site in the United States. in this study patients will be placed in a room with the Notal Vision Home OCT device and following a completion of a self tutorial will perform 3 unsupervised self-scans on each study eye (with a rest of \~5 minutes between self-scans). at the end of the testing sessions, the subject will be asked to complete subject user questionnaire.

Conditions

  • Neovascular Age-related Macular Degeneration
  • Intermediate Age Related Macular Degeneration (Disorder)

Sponsors & Collaborators

  • Notal Vision Inc.

    lead INDUSTRY

Principal Investigators

  • Michael Elman, MD · Michael Elman, M.D. 9114 Philadelphia Rd #310 Baltimore, Maryland 21237

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-16
Primary Completion
2021-08-24
Completion
2021-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04642183 on ClinicalTrials.gov